查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1947431

側向層析檢測市場：依產品、技術、應用、終端用戶和地區劃分 - 全球預測至 2036 年

Lateral Flow Assays Market by Product, Technique, Application, End User, and Geography-Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 194 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2026 年全球側向層析檢測 (LFA) 市場規模為 137 億美元，預計到 2036 年將達到約 274 億美元，預測期內（2026-2036 年）複合年增長率 (CAGR) 為 7.9%。

本報告對五大主要地區的側向層析檢測市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至 2036 年的預測。透過廣泛的二級和一級研究以及對市場現狀的詳細分析，我們對關鍵產業驅動因素、限制因素、機會和挑戰進行了影響分析。推動側向層析檢測市場成長的關鍵因素包括對快速診斷測試的需求不斷增長、傳染病日益普遍以及即時檢測解決方案的日益普及。 此外，與數位和行動閱讀器技術的整合、多重檢測技術的擴展、對居家檢測日益增長的重視，以及獸醫診斷和食品安全領域新應用的開發，預計將為側向流動檢測市場的企業創造顯著的增長機會。

市場區隔

目錄

第一章：引言

第二章：研究方法

第三章：摘要整理

第四章：市場洞察

  • 驅動因素
    • 與實驗室檢測相比，基於側向流動檢測的快速檢測的優勢
    • 居家側向流動檢測的日益普及
    • 即時檢測的需求不斷增長檢測
    • 慢性病和傳染病患者病率上升
    • 智慧型裝置普及率上升
  • 限制因素
    • 側向層析檢測結果的變異性
  • 機遇
    • 側向層析偵測應用範圍擴大
    • 食品飲料產業需求成長
  • 挑戰
  • 診斷方法變革的阻力
  • 多重檢測技術的開發

第五章 全球側向層析檢測市場（依產品分類）

  • 試劑盒和試劑
  • 側向層析閱讀器
    • 數位/行動閱讀器
    • 桌上型閱讀器讀者

第六章：全球側向層析檢測市場（依技術劃分）

  • 夾心法檢測
  • 競爭法檢測
  • 多重偵測

第七章：全球側向層析檢測市場（依應用劃分）

  • 臨床檢測
    • 傳染病檢測
    • 懷孕與不孕症檢測
    • 心臟標記檢測
    • 膽固醇檢測/血脂分析
    • 藥物濫用檢測
    • 其他臨床檢測
  • 獸醫診斷
  • 食品安全與環境檢測
  • 藥物開發與品質檢測

第八章：全球側向層析檢測市場（依終端用戶劃分）

  • 醫院和診所
  • 診斷實驗室
  • 家庭醫療保健機構
  • 製藥和生技公司
  • 其他終端用戶

第九章：依地區劃分的市場

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 拉丁美洲
  • 中東和非洲

第十章：競爭情形

  • 關鍵成長策略
  • 競爭標竿分析
  • 市佔率分析

第11章 企業簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux S.A.
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Quidel Corporation
  • Merck KGaA
  • Others

第12章 附錄

簡介目錄
Product Code: MRHC - 104471

Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036

According to the research report titled, 'Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036,' the global lateral flow assays (LFA) market is valued at USD 13.7 billion in 2026 and is expected to reach approximately USD 27.4 billion by 2036, at a CAGR of 7.9% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global lateral flow assays market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the lateral flow assays market include increasing demand for rapid diagnostic testing, growing prevalence of infectious diseases, and widespread adoption of point-of-care testing solutions. Additionally, digital and mobile reader technology integration, multiplex detection expansion, home-based testing emphasis, and emerging application development in veterinary diagnostics and food safety are expected to create significant growth opportunities for players operating in the lateral flow assays market.

Market Segmentation

The lateral flow assays market is segmented by product (kits & reagents, lateral flow readers), technique (sandwich assays, competitive assays, multiplex detection assays), application (clinical testing, veterinary diagnostics, food safety & environment testing, drug development & quality testing), end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, kits and reagents represent the largest segment in the lateral flow assays market in 2026, attributed to the high volume of diagnostic tests performed globally and the recurring nature of kit and reagent purchases. Digital and mobile lateral flow readers are the fastest-growing product segment, providing quantitative results and eliminating subjectivity associated with visual interpretation. These readers enable data transmission to electronic health records and laboratory information systems, improving workflow efficiency.

Based on Technique

By technique, sandwich assays, competitive assays, and multiplex detection assays represent the key technical approaches in the market. Multiplex lateral flow assays capable of detecting multiple analytes simultaneously are a significant market trend, enabling comprehensive diagnostic evaluation in a single test and improving efficiency while reducing testing costs.

Based on Application

By application, clinical testing is the largest segment, driven by widespread use of rapid diagnostic tests in healthcare settings. Infectious disease testing, including tests for COVID-19, influenza, and other respiratory pathogens, represents the largest sub-segment. Emerging applications in veterinary diagnostics, food safety testing, and drug development are creating new market opportunities. Pregnancy and fertility testing, cardiac marker testing, and cholesterol screening are additional clinical applications driving market growth.

Based on End User

By end user, hospitals and clinics hold the largest share, driven by high volume of diagnostic testing performed in these settings. Home care settings are experiencing rapid growth in lateral flow assay adoption, driven by increasing emphasis on home-based testing and self-diagnostics. Diagnostic laboratories, research institutions, and veterinary clinics represent additional end-user segments.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to hold the largest market share for lateral flow assays, driven by advanced healthcare infrastructure, high healthcare spending, and strong regulatory frameworks. Europe is projected to experience steady growth, driven by supportive regulatory frameworks and adoption of point-of-care testing. Asia-Pacific is emerging as the fastest-growing region, with increasing healthcare spending, improving healthcare infrastructure, and growing awareness of diagnostic testing in countries such as China, India, and Japan.

Key Players

The key players operating in the global lateral flow assays market are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Biomerieux S.A., QIAGEN N.V., PerkinElmer, Inc., Quidel Corporation, Merck KGAA, and various other regional and emerging manufacturers, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the lateral flow assays market globally?
  • At what rate is the global lateral flow assays market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global lateral flow assays market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of product, technique, application, and end user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global lateral flow assays market?
  • Who are the major players in the global lateral flow assays market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global lateral flow assays market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Lateral Flow Assays Market Assessment -- by Product

  • Kits & Reagents
  • Lateral Flow Readers

Lateral Flow Assays Market Assessment -- by Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

Lateral Flow Assays Market Assessment -- by Application

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Lateral Flow Assays Market Assessment -- by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Research Institutions
  • Veterinary Clinics
  • Other End Users

Lateral Flow Assays Market Assessment -- by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Southeast Asia
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for this Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Benefits of LFA-Based Rapid Tests over Laboratory Tests
    • 4.2.2. Increasing Usage of Home-Based Lateral Flow Assays
    • 4.2.3. Growing Demand for Point-of-Care Testing
    • 4.2.4. Growing Prevalence of Chronic & Infectious Diseases
    • 4.2.5. Growing Acceptance of Smart Devices
  • 4.3. Restraints
    • 4.3.1. Variability in Lateral Flow Assay Test Results
  • 4.4. Opportunities
    • 4.4.1. Evolving Applications of Lateral Flow Assays
    • 4.4.2. Rising Demand in Food & Beverage Industry
  • 4.5. Challenges
    • 4.5.1. Reluctance Toward Changing Diagnostic Practices
    • 4.5.2. Development of Multiplexing Assays

5. Global Lateral Flow Assays Market, by Product

  • 5.1. Introduction
  • 5.2. Kits & Reagents
  • 5.3. Lateral Flow Readers
    • 5.3.1. Digital/Mobile Readers
    • 5.3.2. Benchtop Readers

6. Global Lateral Flow Assays Market, by Technique

  • 6.1. Introduction
  • 6.2. Sandwich Assays
  • 6.3. Competitive Assays
  • 6.4. Multiplex Detection Assays

7. Global Lateral Flow Assays Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Testing
    • 7.2.1. Infectious Disease Testing
    • 7.2.2. Pregnancy & Fertility Testing
    • 7.2.3. Cardiac Marker Testing
    • 7.2.4. Cholesterol Testing/Lipid Profile
    • 7.2.5. Drug Abuse Testing
    • 7.2.6. Other Clinical Tests
  • 7.3. Veterinary Diagnostics
  • 7.4. Food Safety & Environmental Testing
  • 7.5. Drug Development & Quality Testing

8. Global Lateral Flow Assays Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Home Care Settings
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Other End Users

9. Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis

11. Company Profiles

  • 11.1. Abbott Laboratories
  • 11.2. F. Hoffmann-La Roche AG
  • 11.3. Becton, Dickinson and Company
  • 11.4. Siemens Healthineers AG
  • 11.5. Thermo Fisher Scientific, Inc.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. bioMerieux S.A.
  • 11.8. QIAGEN N.V.
  • 11.9. PerkinElmer, Inc.
  • 11.10. Quidel Corporation
  • 11.11. Merck KGaA
  • 11.12. Others

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization